Loading stock data…
SKIN
$0.64+0.00 (+0.68%)
Market OpenUpdated 3:49 PM EDT
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
SkinHealth Systems Inc. in the Consumer Defensive sector is trading at $0.64 with a market capitalization of $82M. Wall Street consensus targets $1.34 (6 analysts), implying a +110.2% move over the next 12 months. The stock is currently near its 52-week low of $0.55, remaining 51.6% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +110.2% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$0.64
Potential Downside
0%
Whystock Fair Value$0.64
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship produ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$82.15M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.12
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-10.96%
Volume
Today's trading volume
327,588
Recent News
How The Investment Story For SkinHealth Systems (SKIN) Is Shifting After Guidance And Fair Value Reset
SkinHealth Systems is back in focus after the updated fair value estimate fell about 21% from US$1.69 to US$1.34, while some analysts are still pointing to a lower but intact price target of US$2.00. Bulls and bears are working from the same reset, using the revised target to argue either for patience as the story plays out or for caution around execution and competitive pressure. In the sections that follow, you will see what is driving these views and how to follow the evolving narrative...
Why SkinHealth Systems Inc. (SKIN) International Revenue Trends Deserve Your Attention
Explore how SkinHealth Systems Inc.'s (SKIN) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Beauty Health Q1 Earnings Call Highlights
Beauty Health (NASDAQ:SKIN), referred to by executives as SkinHealth Systems following a recent rebrand, reported first-quarter 2026 net sales of $64.9 million, down 6.7% from the prior year, as weaker device placements continued to weigh on growth. The company said adjusted EBITDA rose 17% year ove
SkinHealth Systems Inc. (SKIN) Reports Q1 Loss, Lags Revenue Estimates
SkinHealth Systems Inc. (SKIN) delivered earnings and revenue surprises of +41.18% and -1.85%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Compared to Estimates, SkinHealth Systems Inc. (SKIN) Q1 Earnings: A Look at Key Metrics
The headline numbers for SkinHealth Systems Inc. (SKIN) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.